Start-up fund manager Abhinav Shah reveals how the Rosevine Capital Global Equity Fund has performed during the coronavirus crisis.
There are a handful of investment trusts that consistently trade at a premium and that can take advantage by issuing new shares.
Some funds will take years to recover the losses incurred in the last three months, but Nick Sudbury says others that thrive in the current environment.
Nick Sudbury takes a look at the impact of missed dividend payments and assesses which funds and trusts might perform better than others.
The specialist healthcare and biotech investment trusts have been one of the best performing areas of the market during the pandemic and have delivered excellent long-term returns.
How you plan for and react to extreme events like the recent sell-off will go a long way towards determining the sort of long-term returns you are going to make, writes Nick Sudbury.
Infrastructure is a defensive type of holding that is well-placed to protect its dividends, writes Nick Sudbury.
It is too early to be overly confident, but we are gradually building confidence in the outlook for the market, writes Jamie Ross of Henderson EuroTrust.
The flight to safety has sent high-yield bond prices plummeting, but the market may well have over reacted.
Ben Lofthouse, Head of Global Equity Income, and Jane Shoemake, Investment Director, assess the outlook for global dividends in the wake of the COVID-19 pandemic.
